Case Report {#sec1-1}
===========

A 60 year old man had a past history of smoking, non-alcoholic steatohepatitis and a left ileofemoral bypass with a Polyethylene Terephthalate (Dacron) graft 7 years earlier. His only regular medication was esomeprazole. He became unwell during a trip to the United Kingdom, with sore throat, fevers and sweats. On return to Australia, fever and night sweats persisted, and he had 8 kg weight loss. Four weeks later he presented with back pain, an abdominal computed tomography (CT) scan revealed a para-aortic mass ([Figure 1](#fig001){ref-type="fig"}), and he was referred to our emergency department for further management. On examination he was afebrile, heart rate 60 beats/min, normotensive with a pulsatile non-tender abdominal mass. White cell count (WCC) was 13.9×10^9^/L and C-reactive protein (CRP) 207 mg/L. As he was clinically stable, empiric antibiotic therapy was withheld. Multiple blood cultures were obtained and a CT-guided biopsy of the periaortic mass was performed. Following the biopsy, he developed fever (40°C) and rigors, and intravenous ceftriaxone 2 g every 24 hours, vancomycin 1.5 g every 12 hours and metronidazole 500 mg every 12 hours were commenced. Blood cultures and biopsy specimens revealed pure growth of *Streptococcus pyogenes,* later confirmed as *emm* type 44. Antimicrobial therapy was modified to iv benzylpenicillin 2.4 g q4h alone. Transoesophageal echocardiography revealed no evidence of endocarditis. He was progressing well until day 7 when he developed worsening abdominal pain. Repeat abdominal CT scan revealed a contained rupture of the aneurysm. He underwent urgent endovascular aortic aneurysm stent graft repair. Fever resolved in 72 hours, and inflammatory markers reduced (Day 4: WCC 15.3×10^9^/L and CRP 430 mg/L; Day 13 WCC 6.8×10^9^/L and CRP 66 mg/L). He was discharged on day 15 and continuous infusion intravenous benzylpenicillin was continued via an outpatient antimicrobial therapy program, with a plan for 6 weeks therapy followed by lifelong oral amoxicillin.

However he had ongoing weight loss, anorexia, his inflammatory markers failed to normalise. On day 53, he underwent graft explantation and axillo-bifemoral bypass. This was complicated by graft occlusion requiring therapeutic anticoagulation, and subsequent intra-abdominal haemorrhage. This ultimately resulted in irreversible ischemia of his left lower limb requiring below knee amputation. Culture of the explanted graft revealed *Klebsiella oxytoca*, *Enterococcus faecalis*, and methicillin-sensitive *Staphylococcus capitus* and *Staphylococcus epidermidis*, but *Streptococcus pyogenes* was not reisolated. Repeat CT imaging revealed no source of infection, and there was no evidence of intestinal pathology at the time of laparotomy. He was treated with intravenous piperacillin/tazobactam 4.5 g every 8 hours for a further 6 weeks, followed by oral amoxicillin/clavulanate, with a plan for lifelong antimicrobial therapy. On review 4 months after the initial presentation, he was recovering uneventfully and inflammatory markers had normalised.

Discussion {#sec1-2}
==========

*Streptococcus pyogenes* is an organism associated with a diverse range of clinical presentations. It has multiple virulence factors facilitating pus liquefaction and spread through tissue planes, which give it the ability to cause highly invasive infections such as necrotizing fasciitis. *S. pyogenes* is not typically thought to be associated with endovascular infections. Interestingly, infectious diseases textbooks state that in the pre-antibiotic era *S. pyogenes* was often associated with endovascular infections,[@ref1] along with *Streptococcus pneumoniae* and *Haemophilus influenzae*. A review of the limited available primary data from this time however suggests that the predominant organisms were viridans streptococci, and *S. pyogenes* was in fact unusual. In a widely-referenced 1923 review of 217 cases of *mycotic* aneurysms (mostly associated with endocarditis), Stengel and Wolfert comment *the organisms most frequently recovered from blood cultures from the heart valves or from aneurysms have been streptococci, mostly non-haemolytic types*.[@ref2] Another early review by Revell *et al*.[@ref3] examines 24 cases of primary *mycotic* aneurysm from 1905-1939, of which 13 had a causative organism identified, 6 of which were *streptococci* (no further details available). The term *mycotic*, initially used to refer to all microorganisms, has for some time now been reserved for fungal infections. *Mycotic aneurysm* has persisted for longer, but has now been surpassed by the more accurate *infected aortic aneurysm*.

The introduction of penicillin had a dramatic effect on the overall incidence and epidemiology of infected aortic aneurysms. There has been a shift away from an association with endocarditis, and although streptococci remain important causative organisms, *Staphylococcus aureus* and *Salmonella* species predominate.[@ref4]

We identified eight cases of infected aortic aneurysm due to *S. pyogenes* described in the literature ([Table 1](#table001){ref-type="table"}).[@ref5] One died soon after presentation following aneurysm rupture, but seven patients underwent early open surgical repair. Our case represents the first reported case of initial endoluminal repair. Five of seven patients survived the initial post-operative period and were treated with prolonged periods of intravenous and oral penicillin (6 weeks to 1 year), although details of antibiotic treatment were not available for all cases. Surviving patients were reported to be well at follow-up, ranging from 6 weeks to 87 months.

No randomized controlled trials are available to guide management of infected aortic aneurysm. Given the wide spectrum of potential organisms, obtaining a microbiological diagnosis is of critical importance. There is a high mortality rate associated with conservative therapy. Intervention should be timed before rupture if possible, as emergency procedures have a higher risk of complications. Interestingly, gram-negative aneurysms are more likely to rupture early (80% within 2 weeks versus 10% for gram positives).[@ref1]

Surgical options include open debridement with either extra-anatomic bypass or local reconstruction, endovascular repair, a hybrid approach, or a staged procedure. Anatomical location is a key factor, with an endovascular approach ideal for difficult-to-access descending thoracic aneurysms, but open repair traditionally preferred for juxta- and infra-renal aneurysms.[@ref13]

Endoluminal repair is rapidly becoming an increasingly popular treatment option for the repair of non-infected aortic aneurysms. Advantages include a smaller incision, shorter operation time with less blood loss and transfusion requirements and reduced intensive care stay. It does not require cardiopulmonary bypass, aortic cross-clamping, or single lung ventilation, and overall has reduced early morbidity and mortality, with equivalent long-term outcomes.[@ref14] It is a tempting option for infected aneurysms as well, particularly in high-risk patients. It does not however allow adequate surgical debridement of the infected area, leading to concern regarding the long-term consequences of direct insertion of prosthetic material into an infected field, and slower uptake in this area.[@ref15]

Setacci *et al*.[@ref16] review 6 retrospective studies comparing endovascular with open approaches for management of infected aortic aneurysm. In general, an endovascular approach seems to be associated with a lower 30-day mortality, but higher rate of late deaths and complications. It seems to be a reasonable approach either as a bridge to surgery or in patients who are not candidates for surgery due to age or comorbidities, but can be associated with secondary infection and graft failure. Patients who undergo primary surgery seem to have a higher early mortality rate but possibly a better chance of definitive cure with long-term survival.

In our case, after an initial phase of antibiotic therapy, an urgent endovascular repair was performed due to contained rupture. Although there was initial response to directed antibiotic therapy, deterioration then occurred, requiring endograft excision and axillarybifemoral bypass grafting. Culture of explanted graft revealed polymicrobial secondary infection, requiring a prolonged course of broadspectrum intravenous antibiotics and likely lifelong oral suppressive antibiotics.

Conclusions {#sec1-3}
===========

Aortic aneurysm infection is a serious disease with a high mortality rate. We describe a complicated case secondary to *S. pyogenes*, a rare causative pathogen, who initially underwent endoluminal repair. Well-timed intervention in conjunction with effective antibiotics can result in reasonable long-term survival. Directed antimicrobial therapy in combination with complete surgical excision of the infected aorta remains the optimal treatment. Endoluminal repair is an emerging treatment option in particular for those with comorbidities contraindicating surgery, but long term monitoring for secondary infection is recommended.

![Contrast-enhanced coronal section of abdominal CT scan showing the infrarenal sacular mycotic aneurysm (see arrow) on presentation (A) and following contained rupture (B).](idr-2013-2-e11-g001){#fig001}

###### 

Reported cases of Streptococcus pyogenes aortic aneurysm infection.

  Case (ref)           Age /Sex   Site                                                                Surgical treatment                                                                                                          Medical treatment (empiric; directed)                                                                                                       Outcome
  -------------------- ---------- ------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------
  1(5)                 65/M       Infrarenal abdominal aorta                                          Resection with right axillary femoro-femoral bypass graft (day 1)                                                           Ampicillin-sulbactam & aztreonam: nafcillin & penicillin G                                                                                  Died 40 hours after admission
  2(6)                 58/F       Infrarenal abdominal aorta                                          Aorto-bifemoral graft                                                                                                       Not discussed "antibiotics"                                                                                                                 Lumbar plexopathy and flaccid paralysis; walking with sticks at 18 months
  3(7)                 36/M       Aberrant origin right subclavian artery                             Ligation of aberrant artery; aortic arch repair with Hemashield graft (day2)                                                Not discussed "parenteral antibiotics"                                                                                                      Death day 8 -- brain death due to diffuse brain ischemia, obstructive hydrocephalus due to cerebellar infarct, & transverse sinus thrombosis
  4(8)                 1.5/F      Ascending aorta                                                     Aneurysmectomy + valveless aortic homograft on day 8                                                                        Cefuroxime & gentamicin; high dose penicillin G (6 weeks), oral penicillin (3 months)                                                       Well and active at 12 months
  5(9)                 81/M       Abdominal aorta, vertebral osteomyelitis, bilateral psoas abscess   None                                                                                                                        Not discussed                                                                                                                               Died (aneurysm rupture)
  6(10)                72/M       Thoraco-abdominal aorta                                             Open resection & prosthetic graft implanatation (rifampicin-impregnated)                                                    Vancomycin & imipenem; penicillin G (4 million units q4h 12 days), benzathine penicillin 1yr                                                Well at 6 months on penicillin
  7(11)                63/F       Thoraco-abdominal aorta                                             Open Type IV repair (3 weeks after diagnosis)                                                                               Not discussed                                                                                                                               Alive at 87 months
  8(12)                2/M        Descending thoracic aorta                                           Open Dacron repair (day 3) and re-operation due to recurrence proximal to original graft                                    Ceftriaxone, ampicillin-sulbactam; clindamycin & ampicillin (6 weeks)                                                                       Well at 6 weeks
  9 (current report)   60/M       Infrarenal abdominal aorta                                          Initial endoluminal repair, complicated by secondary graft infection requiring graft excision & axillary-bifemoral bypass   Vancomycin, ceftriaxone & metronidazole; benzylpenicillin (5 weeks) piperacillin-tazobactam (6 weeks), amoxicillin-clavulanate (lifelong)   Well at 4 months, on amoxicillin-clavulanate

[^1]: Contributions: BJ, patient care, primary author; JW, patient care, secondary author; MY, treating surgeon, contributing author, approval of manuscript; TB, interventionalist, contributing author, approval of manuscript; TK, patient care, supervising author.

[^2]: Conflict of interests: the authors declare no potential conflict of interests.
